Abstract
The incidence of most types of cancers is age-dependent and the progressive ageing is rapidly increasing the number of elderly people who need treatment for cancer. Elderly patients present peculiar characteristics that make the choice of the correct treatment more difficult and these patients are often undertreated. Moreover, elderly patients are largely underrepresented in cancer treatment trials, and this makes the experimental evidence on this topic even weaker. Health-related Quality of Life (QOL) has been considered as one of the hard end-points for clinical cancer research, and treatment of elderly cancer patients represents a typical situation where its assessment can be particularly useful, because the expected toxicity of treatment could be relevant in the discussion of the treatment choice. However, QOL assessment in the elderly is complicated by several unresolved methodological problems (higher frequency of illiteracy, worse compliance with the questionnaires, concomitant diseases, use of instruments not validated in the aged population). Conduct of clinical trials dedicated to elderly patients is now encouraged but there are few published studies. Advanced non-small-cell lung cancer is one of the fields with the largest amount of research on QOL in elderly patients. The ELVIS study demonstrated the efficacy of single-agent chemotherapy, both in terms of QOL and of survival. The MILES study, in which combination chemotherapy was not superior than single agents, showed that baseline QOL is a strong prognostic indicator in these patients. QOL of patients with breast cancer has been another important field in clinical research over the last decades, and interest on this topic in elderly patients is growing, from loco-regional to palliative treatment.In conclusion, some steps have been done in clinical cancer research dedicated to elderly patients, and the role of QOL assessment in this setting is important. However, many methodological problems must be resolved, in order to obtain reliable and useful results. A QOL assessment could also be useful for elderly patients in clinical practice, where it could improve patient-clinician communication: a wider application of properly selected instruments should be recommended.
Highlights
Some steps have been done in clinical cancer research dedicated to elderly patients, and the role of Quality of Life (QOL) assessment in this setting is important
There is a need for clinical trials dedicated to elderly patients, because results are probably more generalizable to clinical pratice than subgroup analysis of studies without upper age limit
These patients probably carry a better prognosis and higher treatment compliance than the whole elderly population. Information derived from this kind of selected patients, in the case of trials with aggressive and toxic treatment approaches, can be misleading and dangerous if generalised to clinical practice [32]
Summary
There is a need for clinical trials dedicated to elderly patients, because results are probably more generalizable to clinical pratice than subgroup analysis of studies without upper age limit. Scientific community is often facing the problem of underrepresentation of elderly patients in clinical trials, and it seems easy to predict for the near future a growing number of studies dedicated to elderly patients, probably with a majority of these studies providing a Quality of Life assessment As described, this assessment in the elderly is still complicated by several unresolved methodological problems (frequency of illiteracy, worse compliance with the questionnaires, influence of concomitant diseases, use of instruments not validated in the aged population). A Quality of Life assessment in clinical practice seems useful for elderly patients, allowing better communication between patient and clinician, and a wider application of properly selected instruments should be recommended
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.